Several of the PD biomarkers are also dysregulated in Alzheimer’s disease including c5orf4, slc14a1, macf1, znf160 and mpp1 [48], [49]. This evidence concerns the gene ZNF160 and early-onset autosomal dominant Alzheimer disease.